Table 2. Age-specific seroprevalence estimates based on the MSP-119 antibody in Miton, Haiti in 1998.
Age Category (years) | Median Age (years) | N | % | 95% CI |
[0–5) | 2 | 51 | 6 | (1, 16) |
[5–10) | 7 | 67 | 13 | (6, 24) |
[10–15) | 12 | 82 | 34 | (24, 45) |
[15–20) | 16 | 43 | 49 | (33, 65) |
[20–30) | 24 | 51 | 57 | (42, 71) |
[30–40) | 33 | 32 | 53 | (35, 71) |
[40–90] | 50 | 57 | 54 | (41, 68) |
All ages [0–90] | 14 | 383 | 36 | (31, 41) |
Ages [0–11] | 7 | 157 | 14 | (9, 20) |
N is number of individuals.
CI: Confidence Interval.